Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia

Author:

Chen Yun12,Chen Liguang1,Yu Jian1,Ghia Emanuela M.1,Choi Michael Y.1,Zhang Ling1,Zhang Suping13ORCID,Sanchez-Lopez Elsa45ORCID,Widhopf George F.1,Messer Karen1,Rassenti Laura Z.1,Jamieson Catriona16,Kipps Thomas J.13ORCID

Affiliation:

1. Moores Cancer Center, University of California, San Diego, La Jolla, CA;

2. Edmond H. Fischer Translational Medical Research Laboratory, Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China;

3. Guangdong Key Laboratory for Genome Stability & Disease Prevention, Department of Pharmacology, International Cancer Center, Shenzhen University Health Science Center, Shenzhen, Guangdong, China; and

4. Department of Pharmacology and

5. Department of Pathology, School of Medicine, and

6. Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA

Abstract

Key Points Nurse-like cells express Wnt5a to induce ROR1-dependent stimulation of NF-κB, which leads to autocrine IL-6-induced STAT3 activation in CLL cells. Cirmtuzumab inhibits Wnt5a-induced, ROR1-dependent stimulation of NF-κB, and thereby represses autocrine IL-6-dependent STAT3 activation in CLL.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3